Log In
Print
BCIQ
Print
Print this Print this
 

Ferric trimaltol (ST10)

  Manage Alerts
Collapse Summary General Information
Company Shield Therapeutics AG
DescriptionOral ferric iron non-covalently bound to 3 maltol molecules
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationAnemia
Indication DetailsTreat iron deficiency anemia associated with chronic kidney disease (CKD); Treat iron deficiency anemia associated with Crohn's disease; Treat iron deficiency anemia associated with inflammatory bowel disease (IBD); Treat iron deficiency anemia associated with ulcerative colitis (UC); Treat iron deficiency anemia in pre-dialysis patients with chronic kidney disease (CKD)
Regulatory Designation

Partner

AOP Orphan Pharmaceuticals AG


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today